3.99M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.

Similar securities

Based on sector and market capitalization

Report issue